NorthSea Therapeutics B.V.   Report issue

For profit Phase 1 Phase 2
Founded: Naarden Netherlands (2017)

Organization Overview

First Clinical Trial
2018
NCT03577275
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

NorthSea Therapeutics B.V.